Literature DB >> 10757089

Apoptosis and pathogenesis of viral hepatitis C--an update.

A Nasir1, H S Arora, H E Kaiser.   

Abstract

Hepatitis C virus is a major causative agent of chronic liver disease. Viral genotype, mutations, virus-host interaction, expression of viral proteins and host immune-reaction are important factors in the pathogenesis of HCV infection. Precise pathogenesis and perpetuation of hepatocellular injury in hepatitis C viral infection remain unclear. Proposed mechanisms include direct viropathic effect, the host immune response mediated through cytotoxic T lymphocytes, both viropathic and cytopathic effects, and macrophages/monocytes. Apoptosis occurs both in acute or chronic hepatitis and has been suggested to be mediated through Fas antigen. In HCV infection, Fas expression is up-regulated in the liver cells in line with the severity of liver inflammation. When HCV-specific T cells migrate into hepatocytes and recognize the viral antigen via the T cell receptor, they become activated and express Fas ligand that transduces the apoptotic death signal to Fas-bearing hepatocytes resulting in their destruction. Thus, the Fas system plays an important role in liver cell injury by HCV infection. Possible inducers of apoptosis in hepatitis C include cytokines, especially tumor necrosis factor-alpha (TNF-alpha), released by inflammatory cells, and acting through TNF and other cytokine receptors.

Entities:  

Mesh:

Year:  2000        PMID: 10757089

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  7 in total

1.  Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA.

Authors:  Jashmin Vyas; Androulla Elia; Michael J Clemens
Journal:  RNA       Date:  2003-07       Impact factor: 4.942

2.  p53-Independent induction of Fas and apoptosis in leukemic cells by an adenosine derivative, Cl-IB-MECA.

Authors:  Seong Gon Kim; Gnana Ravi; Carsten Hoffmann; Yun Jin Jung; Min Kim; Aishe Chen; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2002-03-01       Impact factor: 5.858

3.  Expression of bcl-2 protein in chronic hepatitis C: effect of interferon alpha 2b with ribavirin therapy.

Authors:  Panasiuk Anatol; Prokopowicz Danuta; Dzieciol Janusz; Panasiuk Bozena
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

4.  Possible correlation between iron deposition and enhanced proliferating activity in hepatitis C virus-positive hepatocellular carcinoma in Myanmar (Burma).

Authors:  Kyaw Soe; Yoshitaka Hishikawa; Yoshitaka Fukuzawa; Ne Win; Khine San Yin; Khin Maung Win; Aye Aye Myint; Takehiko Koji
Journal:  J Gastroenterol       Date:  2007-03-30       Impact factor: 7.527

5.  Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression.

Authors:  Nicholas A Shackel; Peter H McGuinness; Catherine A Abbott; Mark D Gorrell; Geoffrey W McCaughan
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

6.  Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model.

Authors:  Carolina Soguero; Myungsoo Joo; Kimberly A Chianese-Bullock; Duong Tony Nguyen; Kenneth Tung; Young S Hahn
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Leishmania-released nucleoside diphosphate kinase prevents ATP-mediated cytolysis of macrophages.

Authors:  Bala Krishna Kolli; Jan Kostal; Olga Zaborina; Ananda M Chakrabarty; Kwang-Poo Chang
Journal:  Mol Biochem Parasitol       Date:  2007-12-25       Impact factor: 1.759

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.